Lindsey A Burnett1, Baylie R Hochstedler2, Kelly Weldon3, Alan J Wolfe2, Linda Brubaker4. 1. Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego, La Jolla, California, USA. 2. Department of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA. 3. Center for Microbiome Innovation, University of California, San Diego, La Jolla, California, USA. 4. Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego, La Jolla, California, USA.
Abstract
AIMS: Clinical profiles of women with recurrent urinary tract infection (RUTI) are correlated with their urinary microbes. METHODS: This IRB-approved, cross-sectional study enrolled adult women with RUTI. Urine samples (catheterized and voided) underwent culture by expanded quantitative urine culture (EQUC) and standard urine culture (SUC) methods. A validated symptom questionnaire, relevant clinical variables, and EQUC were used to identify symptom clusters and detect associations with specific urinary microbes. RESULTS: Most (36/43) participants were postmenopausal; the average age was 67 years. 51% reported vaginal estrogen use; 51% reported sexual activity. Although single symptoms were not associated with specific urinary microbes, EQUC results were correlated with five distinct clinical profile clusters: Group A: odor, cloudiness, and current vaginal estrogen use (no culture result association). Group B: frequency, low back pain, incomplete emptying, and vaginal estrogen (significantly increased proportion of Lactobacillus-positive cultures). Group C: pain/burning, odor, cloudiness, and urgency (high proportions of UTI-associated microbe-positive cultures). Group D: frequency, urgency, pain/burning, and current vaginal estrogen use (increased number of no growth cultures). Group E: frequency, urgency, pain/burning, odor, overactive bladder, and sexually active (significantly increased proportion of Klebsiella-positive cultures). CONCLUSIONS: Distinct clinical profiles are associated with specific urinary microbes in women with RUTI. Refined assessments of clinical profiles may provide useful insights that could inform diagnostic and therapeutic considerations.
AIMS: Clinical profiles of women with recurrent urinary tract infection (RUTI) are correlated with their urinary microbes. METHODS: This IRB-approved, cross-sectional study enrolled adult women with RUTI. Urine samples (catheterized and voided) underwent culture by expanded quantitative urine culture (EQUC) and standard urine culture (SUC) methods. A validated symptom questionnaire, relevant clinical variables, and EQUC were used to identify symptom clusters and detect associations with specific urinary microbes. RESULTS: Most (36/43) participants were postmenopausal; the average age was 67 years. 51% reported vaginal estrogen use; 51% reported sexual activity. Although single symptoms were not associated with specific urinary microbes, EQUC results were correlated with five distinct clinical profile clusters: Group A: odor, cloudiness, and current vaginal estrogen use (no culture result association). Group B: frequency, low back pain, incomplete emptying, and vaginal estrogen (significantly increased proportion of Lactobacillus-positive cultures). Group C: pain/burning, odor, cloudiness, and urgency (high proportions of UTI-associated microbe-positive cultures). Group D: frequency, urgency, pain/burning, and current vaginal estrogen use (increased number of no growth cultures). Group E: frequency, urgency, pain/burning, odor, overactive bladder, and sexually active (significantly increased proportion of Klebsiella-positive cultures). CONCLUSIONS: Distinct clinical profiles are associated with specific urinary microbes in women with RUTI. Refined assessments of clinical profiles may provide useful insights that could inform diagnostic and therapeutic considerations.
Authors: Alan J Wolfe; Evelyn Toh; Noriko Shibata; Ruichen Rong; Kimberly Kenton; MaryPat Fitzgerald; Elizabeth R Mueller; Paul Schreckenberger; Qunfeng Dong; David E Nelson; Linda Brubaker Journal: J Clin Microbiol Date: 2012-01-25 Impact factor: 5.948
Authors: Krystal J Thomas-White; Stephanie Kliethermes; Leslie Rickey; Emily S Lukacz; Holly E Richter; Pamela Moalli; Philippe Zimmern; Peggy Norton; John W Kusek; Alan J Wolfe; Linda Brubaker Journal: Am J Obstet Gynecol Date: 2016-08-04 Impact factor: 8.661
Authors: Krystal J Thomas-White; Evann E Hilt; Cynthia Fok; Meghan M Pearce; Elizabeth R Mueller; Stephanie Kliethermes; Kristin Jacobs; Michael J Zilliox; Cynthia Brincat; Travis K Price; Gina Kuffel; Paul Schreckenberger; Xiaowu Gai; Linda Brubaker; Alan J Wolfe Journal: Int Urogynecol J Date: 2015-09-30 Impact factor: 2.894
Authors: Tiago Antunes-Lopes; Luis Vale; Ana Margarida Coelho; Carlos Silva; Malte Rieken; Bogdan Geavlete; Tina Rashid; Sajjad M Rahnama'i; Jean Nicolas Cornu; Tom Marcelissen Journal: Eur Urol Focus Date: 2018-09-28
Authors: Linda Brubaker; Charles W Nager; Holly E Richter; Anthony Visco; Ingrid Nygaard; Matthew D Barber; Joseph Schaffer; Susan Meikle; Dennis Wallace; Noriko Shibata; Alan J Wolfe Journal: Int Urogynecol J Date: 2014-02-11 Impact factor: 2.894
Authors: Sanchutha Sathiananthamoorthy; James Malone-Lee; Kiren Gill; Anna Tymon; Trang K Nguyen; Shradha Gurung; Linda Collins; Anthony S Kupelian; Sheela Swamy; Rajvinder Khasriya; David A Spratt; Jennifer L Rohn Journal: J Clin Microbiol Date: 2019-02-27 Impact factor: 5.948
Authors: Austin Martin; Benjamin L Woolbright; Shahid Umar; Molly A Ingersoll; John A Taylor Journal: Nat Rev Urol Date: 2022-07-07 Impact factor: 16.430
Authors: Lei Huang; Xiangyan Li; Bo Zheng; Pengtao Li; Dali Wei; Chenwei Huang; Liying Sun; Haixia Li Journal: Front Microbiol Date: 2022-05-26 Impact factor: 6.064
Authors: Lena M Biehl; Fedja Farowski; Catharina Hilpert; Angela Nowag; Anne Kretzschmar; Nathalie Jazmati; Anastasia Tsakmaklis; Imke Wieters; Yascha Khodamoradi; Hilmar Wisplinghoff; Maria J G T Vehreschild Journal: PLoS One Date: 2022-01-14 Impact factor: 3.240
Authors: Nazema Y Siddiqui; Li Ma; Linda Brubaker; Jialiang Mao; Carter Hoffman; Erin M Dahl; Zhuoqun Wang; Lisa Karstens Journal: Front Cell Infect Microbiol Date: 2022-07-08 Impact factor: 6.073